Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.
Clinical trial NCT05568693 · UNKNOWN
Trial details
- NCT number
- NCT05568693
- Sponsor
- Yu Qin
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-21
- Primary completion
- 2022-10-15
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.